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Additon of opsonized particles to human neutrophils in suspension leads to a biphasic elevation in the cytosolic free Ca2+ concentration ([Ca*‘],). 
The rise in [Caz’], during the second phase (> 3 min) is pronounced (about 400 nM), in contrast o the rise during the first phase, which is relatively 
small (< 100 nM). The second and large rise in [Ca”], is brought about by messenger(s) released from the cell after addition of opsonized particles. 
This second rise in [Ca*+], is not observed in the presence. of the platelet-activating factor (PAF) antagonist WEB 2086, indicating that PAF can 
act as an intercellular messenger affecting Ca 2+ homeostasis in human neutrophils. 
[Ca*+], cytosolic free; Human neutrophil; Opsonized particle; Platelet-activating factor; Intercellular messenger 
1. INTRODUCTION 
Phagocytosis and killing of bacteria by neutrophils 
are important mechanisms in the host defence against 
invading microorganisms. The killing process is 
mediated by the concomitant release of cytotoxic pro- 
teins and oxygen metabolites into the phagolysosomes. 
The toxic oxygen metabolites are produced in a so- 
called ‘respiratory burst’ [1,2]. In vitro, these processes 
can be activated by the addition of opsonized particles, 
such as serum-treated zymosan (STZ, see e.g. [3]). 
Not much is known about the second messengers that 
mediate the activation of human neutrophils after STZ 
stimulation. Several studies have shown that the 
cytosolic free Ca*+ concentration ([Ca*‘]l) is increased 
upon STZ stimulation [4,5]. In many different cell 
types, changes in [Ca*‘]i are caused by the rapid 
hydrolysis of phosphatidylinositolbisphosphate (PIP*) 
with the subsequent production of inositol-(1,4,5)tris- 
phosphate (IP3) and inositol-( 1,3,4,5)tetrakisphosphate 
(IP4) [6,7]. IP3 has been shown to liberate Ca’+ ions 
from intracellular stores, whereas IP4 has been im- 
plicated in the influx of Ca*+ ions from the extracellular 
medium into the cells [7]. Indeed, some studies have 
shown that activation of human neutrophils with op- 
sonized particles is accompanied by the production of 
IP3, although this response seems to be much slower 
than that caused by stimulation with chemoattractants 
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[5,8]. These results have been interpreted as an indica- 
tion that the opsonin receptors relevant for binding of 
STZ to neutrophils are coupled to a PIP*-dependent 
phospholipase C. However, the possibility of in- 
tercellular messengers in this process has not been ad- 
dressed. 
In the present study, we have reinvestigated the Ca*+ 
response in human neutrophils after STZ stimulation. 
We have found that the rise in [Ca*‘]i consists of two 
phases: a first phase with a relatively small increase in 
[Ca*‘]i and a second phase with a much larger increase. 
This second phase is caused by the production of an in- 
tercellular messenger, most likely platelet-activating 
factor (PAF). 
2. MATERIALS AND METHODS 
2.1. Materials 
STZ was prepared as described [9]. Indo-l/AM (Molecular Probes, 
Junction City, OR, USA) and WEB 2086 were dissolved in dimethyl 
sulfoxide (DMSO) at 1000 times the final concentration for cell in- 
cubations, and stored at - 70°C. WEB 2086 was a kind gift from Dr 
H. Heuer (Boehringer Ingelheim, FRG). All other chemicals were 
reagent grade. ‘Incubation medium’ for the cell incubations contain- 
ed 132 mM NaCI, 6.0 mM KCI, 1.0 mM CaC12, 1.0 mM MgSO.,, 1.2 
mM potassium phosphate, 20 mM Hepes, 5.5 mM glucose and 0.5% 
(w/v) human serum albumin, pH 7.4. 
2.2. Cell isolation 
Blood was obtained from healthy volunteers. Granulocytes were 
purified from the buffy coat of 500 ml blood anticoagulated with 
0.4% (w/v) trisodium citrate (pH 7.4), as described [lo]. After isola- 
tion, the cells were suspended in incubation medium and kept at room 
temperature. 
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2.3. Measurement of oxygen consumption 
Oxygen consumption was measured at 37°C with an oxygen elec- 
trode as described before [lo]. 
2.4. Measurement of cytosolic free calcium 
Cytosolic free Ca+ was measured exactly as described before [l 11. 
In short, prewarmed cells (5 min at 37”C, 25 x 106/ml of incubation 
medium) were incubated with 0.5pM Indo-l/AM for 40 min at 37°C. 
Subsequently, the cells were washed, resuspended in incubation 
medium and kept at room temperature. Fluorescence measurements 
were performed at 37°C in stirred suspensions. Calibration of Indo-l 
fluorescence as a function of [Ca*+]i was determined as follows: to 
saturate all trapped Indo-l with Ca*“, 5 pM digitonin was added to 
the cell suspension. Subsequently, the Indo-l signal was quenched by 
adding OSpM Mn*+. Cytosolic free Ca*+ was calculated as described 
[12], using 250 nM as the Kd for the Indo-l/Ca” complex [13]. 
3. RESULTS 
3.1. Measurement of cytosolic free Cd’ after STZ 
stimulation 
Addition of STZ (0.1 mg/ml) to human neutrophils 
leads to a small increase in [Ca2’]i in the first few 
minutes, as shown in fig. 1. However, after 3.5 f 0.4 
min (mean + SD, n = 5) a second rise in [Ca2+]i occurs 
to values of 509 + 114 nM (mean f SD, n = 5). Part of 
this rise is caused by Ca 2+ influx from the extracellular 
medium, as deduced by measurements of Mn2+ influx 
(see [14], data not shown). 
Although the dose of STZ used in these experiments 
is suboptimal for activation of the respiratory burst, ox- 
ygen uptake increases rapidly up to 40-50’70 of its max- 
imal value, as induced by the optimal concentration of 
STZ (1 mg/ml) (fig.2). For the Ca2+ measurements, 
higher doses of STZ were not applied, because of in- 
terference of the STZ particles with the fluorescence 
signal of Indo-1. A constant rate of oxygen uptake is 
reached within 3 min after addition of STZ. Thus, the 
second large rise in [Ca’+]i after STZ addition occurs 
after activation of the respiratory burst has been com- 
pleted. 
We subsequently tried to determine whether the 
messenger for the second rise in [Ca’+]i is acting intra- 
or intercellularly. For this purpose, the neutrophils 
were stimulated with STZ, and [Ca2+]i was measured. 
time after STZ addation hii) 
Fig. 1. The effect of addition of opsonized particles (STZ) to human 
neutrophils on the [Ca*‘],. ST2 (0.1 mg/ml) was added after 10 min 
preincubation of the cells (2.0x 106/ml of incubation medium) at 
37’C. The figure has been corrected for the change in basal 
fluorescence caused by the addition of the opsonized particles, as 
determined with unloaded cells. Results shown are representative for 
five different experiments. 
time after ST2 addition (min) 
Fig.2. Computer evaluation of the time course of the rate of oxygen 
uptake by human neutrophils after activation with STZ. STZ (0.1 
mg/ml) was added after a 10 min preincubation of the cells (2.0 x lo6 
/ml of incubation medium) at 37°C. Results shown are representative 
for five experiments. 
After the second rise in cytosolic free Ca’+ had occur- 
red (5 min after STZ addition), the cell suspension was 
centrifuged. Part of the supernatant was then added to 
unstimulated cells and [Ca2+]; was measured. As shown 
in fig.3 (trace A), addition of this supernatant induced 
a fast and transient rise in the [Ca’+]i. The same experi- 
ment was carried out with the supernatant of cells that 
had been stimulated with STZ for only one minute. This 
supernatant did not result in changes in (Ca2+]i (fig.3., 
trace B). This experiment suggests that the second rise 
in [Ca2+]i observed after stimulation of neutrophils 
with STZ is due to messengers acting intercellularly. 
3.2. Effect of the PAF-antagonist WEB 2086 on the 
changes in [Cd’]i 
After activation of neutrophils with STZ, two lipid 
mediators are produced which at low concentrations are 
able to elevate [Ca’+]i: PAF and leukotriene B4 (LTB4) 
[15,16]. To investigate the possibility that one of these 
mediators was involved in the [Ca2+]i changes observed 
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Fig.3. The effect of the addition of supernatant of human neutrophils 
that were stimulated with STZ on the [Ca’+]i of human neutrophils. 
STZ (0.1 mg/ml) was added to Indo-l-loaded cells and [Ca*+]i was 
measured. After the second rise in [Ca’+]i had occurred (5 min after 
STZ addition), the cell suspension was centrifuged. Part of the 
supernatant (s) was then added to unstimulated cells and [Ca*+]i was 
measured (trace A). The control experiment was performed with 
supernatant of cells that were stimulated with STZ for only one 
minute (trace B). The figure has been corrected for the change in basal 
fluorescence caused by the addition of supernatant (1 ml) to the cell 
suspension (2 ml), as determined with addition of buffer to the cell 
suspension. Results shown are representative for five experiments. 
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Fig.4. The effect of the PAF antagonist WEB 2086 on the change in 
[Ca”], induced by PAF and LTB4. WEB 2086 (10,uM) or buffer were 
added 2 min prior to PAF (1 nM) or LTB4 (1 nM). The results shown 
are representative for five experiments. 
Fig.5. The effect of the PAF antagonist WEB 2086 on the changes in 
[Ca*‘], induced by STZ (A) and by supernatant of neutrophils that 
were stimulated with STZ for 5 min (B). WEB 2086 (10pM) or buffer 
were added 2 min prior to STZ (0.1 mg/ml, A) or 2 min prior to the 
supernatant (s) of STZ (0.1 mg/ml) stimulated neutrophils (B). (A) 
has been corrected for the change in basal fluorescence induced by the 
addition of the STZ particles, as determined with unloaded cells. (B) 
has been corrected for the change in basal fluorescence induced by the 
addition of supernatant (1 ml) to the cell suspension (2 ml), as 
determined by addition of buffer to the cell suspension. Results 
shown are representative for five experiments. 
with STZ, we first investigated the sensitivity of these 
changes for the PAF-antagonist WEB 2086 [ 171. WEB 
2086 (10 PM) completely inhibited the increase in 
[Ca2+]i induced by 1 nM PAF, while the rise in [Ca2+]i 
induced by 1 nM LTB4 was not affected (fig.4). WEB 
2086 had no influence on the respiratory burst of 
human neutrophils stimulated with STZ (data not 
shown). 
Preincubation of neutrophils with 10 PM WEB 2086 
did not affect the small increase in [Ca’+]i in the first 
minutes after STZ stimulation (figSA). However, the 
second rise in cytosolic free Ca2+ was completely in- 
hibited by 1OpM WEB 2086. This indicates that the se- 
cond rise in [Ca2+]i s caused by the release of PAF, 
which subsequently acts as an intercellular messenger. 
To strengthen this hypothesis, we investigated the effect 
of WEB 2086 on the rise in [Ca2+]i nduced by the 
supernatant of STZ-treated neutrophils. As shown in 
fig.SB, this increase in [Ca’+]i was completely absent 
when the neutrophils were preincubated with 10 PM 
WEB 2086 before addition of the supernatant. 
4. DISCUSSION 
In several studies it has been found that activation of 
human neutrophils with opsonized particles is accom- 
panied by a rise in [Ca2+]i [4,5] and hydrolysis of PIP2 
with the subsequent production of inositolphosphates 
[5,8]. The predominant opsonin on STZ particles is 
iC3b [18,19]. Although these particles also carry IgG 
[3], the binding of this opsonin to Fc-gamma receptors 
on the neutrophil is prevented by steric hindrance by the 
iC3b bound to the Fc region of IgG [3,19]. Thus, it 
could be argued that the iC3b receptor is mediating this 
second messenger esponse via direct activation of 
phospholipase C. However, when STZ is added at a 
concentration that is sufficient to induce 40-50% of the 
maximal respiratory burst activity, only a small rise in 
[Ca2+]i occurs following receptor occupation. We were 
not able to detect increases in inositolphosphates during 
the first 2-3 min after STZ stimulation (data not 
shown). In another study, we have shown that ac- 
cumulation of diglycerides occurs only after prolonged 
(> 90 s) stimulation with STZ [20]. So, if a direct coup- 
ling between the iC3b receptor and a PIPz-dependent 
phospolipase C is present, the rise in IP3, IP4 and 
[Ca”]i resulting from this coupling is only a minor 
event under our experimental conditions. On the other 
hand, a second and much larger rise in [Ca’+]i occurred 
after STZ addition, mediated by an intercellular 
messenger. The potent inhibition of this increase in 
[Ca’+]i by the PAF antagonist WEB 2086 strongly sug- 
gests that this intercellular messenger is identical with 
PAF. Addition of supernatant of neutrophils activated 
with STZ induces a transient rise in the [Ca’+]i, in 
analogy to activation with a single dose of PAF (see 
fig.4). The finding that the second rise in [Ca2’]i after 
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STZ stimulation is a sustained rise, is presumably caus- 
ed by the constant production of PAF by the activated 
neutrophils. Although our data clearly indicate that the 
second rise in [Ca’+]i does not affect the respiratory 
burst, this response may be important for the fusion of 
granules with the phagosomes formed [21]. 
Upon activation of neutrophils with STZ, PAF is 
rapidly produced from (plasmalogen) phosphatidyl- 
choline via activation of phospholipase A2 (PLA2) 
and acetyl-CoA: 1-0-alkyl-sn-glycero-3-phosphocho- 
line-@-acetyltransferase, succesively [22,23]. Our find- 
ings indicate that PAF is synthesized while cytosolic 
free Ca2+ increases only very little (less than 100 nM). 
Presumably, another signal than cytosolic free Ca2+ is 
required for the activation of PLAz. The requirement 
of PLAz for Ca2+ could be lowered by the involvement 
of G-proteins [24]. Interestingly, acetyl-CoA: 1-O-alkyl- 
sn-glycero-3-phosphocholine-d-acetyltransferase, 
which is the rate-limiting step in the synthesis of PAF, 
seems to be controlled by a phosphorylation/dephos- 
phorylation mechanism without requirement of Ca2+ 
WI. 
In summary, our study indicates that a major part of 
the Ca2+ response of neutrophils after stimulation with 
STZ particles is caused by the production of PAF by the 
stimulated cells. Further studies are required to esta- 
blish the mechanism by means of which this autocrine 
response in neutrophils is activated. 
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